Company page

Prothena Corporation Plc

Prothena Corporation Plc is a public company traded under the ticker PRTA in the American market, with a market capitalization of approximately $467.5 million. The company focuses on developing therapies for neurodegenerative diseases and other serious conditions. Prothena is dedicated to advancing its innovative research and drug development efforts.